Cargando…
Breast cancer: Muscarinic receptors as new targets for tumor therapy
The development of breast cancer is a complex process that involves the participation of different factors. Several authors have demonstrated the overexpression of muscarinic acetylcholine receptors (mAChRs) in different tumor tissues and their role in the modulation of tumor biology, positioning th...
Autores principales: | Español, Alejandro, Salem, Agustina, Sanchez, Yamila, Sales, María Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223712/ https://www.ncbi.nlm.nih.gov/pubmed/34189066 http://dx.doi.org/10.5306/wjco.v12.i6.404 |
Ejemplares similares
-
Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells
por: Español, Alejandro, et al.
Publicado: (2022) -
Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy
por: Sales, María E., et al.
Publicado: (2019) -
The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M(2) receptor subtype
por: Español, Alejandro J., et al.
Publicado: (2020) -
Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis
por: Lombardi, María Gabriela, et al.
Publicado: (2013) -
Muscarinic Receptors Associated with Cancer
por: Calaf, Gloria M., et al.
Publicado: (2022)